• Value-based healthcare and Value Labs

    Learn in this In Vivo article how a proposed new approach to value-based contracts could help drive the shift to value-based reimbursements and drug pricing.

  • Participatory health

    Participatory health is transforming the healthcare industry. We examine shifts in emphasis, direction and focus necessary to realise a new and disruptive paradigm.

  • Australia’s diverted profits tax

    The centralization of intellectual property and functions into regional or global hubs is one of the main drivers of efficiency for life sciences multinational enterprises.

  • Cracking the engaged aging code through technology

    A convergence of technological advancements and trends are already underway that could help make the concept of "healthy aging" a reality.

  • Global Corporate Divestment Study: Life sciences

    How can life sciences companies generate a higher price for divestments and use them to fund growth opportunities? Learn more.

  • It’s time to bring drug pricing down

    President Trump himself has said that it’s time to bring drug prices down. Within the industry, some are calling for self-regulation and greater transparency.

  • The 2017 outlook for life sciences

    Pressure on drug pricing, shifting political forces in key markets and potential tax relief in the US support a positive outlook for 2017 life sciences M&A.

  • The drug pricing debate: Managing risks to results

    The unsustainable trajectory of health care spending is generating dialog and consternation across a variety of stakeholders including governments, industry, public, media and academic think-tanks.

  • SEC comments and trends: Life sciences

    Insights into the SEC staff’s areas of focus, based on our analysis of current reporting issues found in filings for public life sciences companies.

生命科學

尋找生物科技、製藥、醫療科技的永續性

歸功於變化迅速而激增的業務決定已成為新常態。從新的市場參與者與法規改革,到過期專利與慢性疾病日益增加的挑戰,在生命科學業中的領導者必須探索新的路徑,著力於健康照護環境的改變—由患者推動並專注於健康成果。

我們的全球科技中心集結全球專業人士,幫助您觸及潛在機會。



相關資訊

 




    聯絡我們

    沈碧琴
    稅務服務部 副營運長
    +886 2 2757 8888 分機 88877

    方文萱
    合夥律師
    +886 2 2757 8888 分機 88861

    詹儒賢
    公司稅務諮詢服務 副總經理
    +886 2 2757 8888 分機 67198

    曹盛凱
    公司稅務諮詢服務 執行總監
    +886 2 2757 8888 分機 67151

    保持聯繫

    請通過網路媒體,電子郵件通知或網路廣播,與我們保持聯繫。

    生物科技產業稅務諮詢服務月刊-當月號

    生物科技產業稅務諮詢服務月刊-當月號

    【2017年7月號:網羅國外優秀人才來台服務】

    生技產業所需人才多元,甚至常需自國外延攬專業人士,然台灣個人所得稅偏高,且陪同來台的配偶未必能合法工作,以致外籍人士來台工作、居住的意願不高。近年來,配合政府延攬外籍人才來台服務的政策,相關法規條文如:「外籍專業人士租稅優惠」及「外國人從事就業服務法」等陸續頒布與更新,相信能吸引更多優秀的外籍人才來台貢獻所長。惟相關法條之適用須注意的細節仍多,期望透過此篇文章引導讀者更了解相關規定及議題。